It has been two years since we formed Sinai Health System to deliver exceptional care in hospital, community and home, focusing on the health conditions with the greatest impact on the overall health of the population. We knew that together, our organizations could deliver better care, ensuring smooth transitions between care settings.
We are pleased to share with you the Top 10 ways our patients benefitted from our integrated approach to care in 2016:
1. Dr. Gary Newton became the first new President and CEO appointed by Sinai Health System: Bridgepoint Active Healthcare, Circle of Care, Mount Sinai Hospital, and the Lunenfeld-Tanenbaum Research Institute. Dr. Newton is leading our teams towards becoming Canada’s leading integrated health system, pushing the boundaries to realize the best health and care from healthy beginnings to healthy aging for people with complex health needs.
2. Hip fracture patients are now experiencing smoother transitions in care between Mount Sinai and Bridgepoint. Sinai Health System patients experienced shorter stays at both Mount Sinai and Bridgepoint: a 19 per cent reduction in length of stay across the system means that patients are able to begin rehabilitation sooner at Bridgepoint, following surgery at Mount Sinai, with better outcomes and a faster return home.
3. A joint department of Obstetrics and Gynecology with Women’s College Hospital was announced, leveraging our individual areas of expertise, giving women more options for care in the downtown core.
4. Access to transportation was made safer and more convenient this year for inpatients within Bridgepoint Active Healthcare’s Orthopedic Rehabilitation Unit thanks to a Circle of Care-led initiative that transports these patients to and from their appointments at Mount Sinai Hospital and local clinics.
5. New system-wide Quality Aims were established, which ensure that all clinical programs are working towards the same goals for achieving high quality and safe care.
6. Dr. Russell Goldman, became our first cross-site physician leader in Palliative Care, providing a consistent approach and smooth transitions across care settings. This includes Bridgepoint’s 32-bed palliative care unit; the Temmy Latner Centre for Palliative Care with its large ambulatory and community/ home- based program and its consultative palliative program at Mount Sinai Hospital; and Circle of Care with its community-based hospice program.
7. Phase 3A of Mount Sinai Hospital’s major capital redevelopment, Renew Sinai, took a step forward this year, with Infrastructure Ontario issuing a Request for Proposals. Phase 3A includes: an expanded emergency department, critical care unit, surgical services, new inpatient rooms, medical device reprocessing, diagnostic areas and ambulatory spaces
8. Access to patient records and information by clinicians at both Bridgepoint Active Healthcare and Mount Sinai Hospital was expanded this year. For example, Bridgepoint patients are now experiencing improved access to diagnostics at Mount Sinai Hospital, including significantly shorter wait times for electrocardiogram (ECG) results. Access to patients records for both sites enables seamless transfers in care.
9. Our innovative Acute Care for Elders Strategy, developed by Dr. Samir Sinha, began implementation across 17 health-care organizations across Canada, through a partnership with The Canadian Foundation for Healthcare Improvement, and Canadian Frailty Network this year. This initiative is an example of how Sinai Health System is spreading its models beyond our own facilities for the benefit of all Canadians.
10. A new trial using an electronic health tool to connect primary care providers with complex patients was developed by Dr. Carolyn Steele Gray and the Collaboratory for Research and Innovation, based out of Bridgepoint Active Healthcare. The ePRO (electronic patient reported outcomes) tool is available for patients who have two or more chronic illnesses and are experiencing challenges in managing their conditions at the Bridgepoint and Mount Sinai Hospital Family Health Teams.
Our Lunenfeld-Tanenbaum Research Institute ranks amongst the top in the world. Here are the Top 6 Research Accomplishments of 2016:
1. Dr. Graham Collingridge, a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute was awarded the world’s most valuable prize for brain research for his work in understanding the mechanisms of memory: the Grete Lundbeck European Brain Research Foundation in Denmark.
2. An association between a unique set of human genes and the makeup of the microbiome was discovered by Dr. Kenneth Croitoru. This finding offers new insights into the link between the community of bacteria living in human bodies, known as the microbiome, and numerous diseases it impacts such as inflammatory bowel disease (IBD), diabetes and rheumatoid arthritis.
3. Drs. Daniel Durocher and Frank Sicheri and collaborators have caught a glimpse of the molecules involved in DNA repair — a process that counteracts DNA damage caused by, for example, radiation or chemicals. Published in Nature, the finding deepens our understanding of how cells see and respond to DNA damage and opens new avenues of research into the process that guards us from mutations that could lead to cancer and other diseases.
4. Bridgepoint’s Collaboratory for Research and Innovation contributed major papers in Longwoods Healthcare Quarterly this year on the subject of adapting and transforming health-care systems for the increasing number of people with complex care needs. Dr. Kerry Kuluski, Dr. Ross Upshur, Dr. Michelle Nelson and Dr. Carolyn Steele-Gray all contributed to the special issue.
5. Dr. Bernard Zinman, one of the world’s most influential diabetes researchers, has shown that for patients with type 2 diabetes who are at higher risk of cardiovascular and kidney disease, a drug called empagliflozin was associated with slower progression of kidney disease and lower rates of clinically relevant renal events. Last year, another one of his major studies showed the same to be true for cardiovascular disease.
6. Anne-Claude Gingras and Laurence Pelletier used cutting edge microscopy and protein identification technology to map out how our cells use key enzymes called kinases and phosphatases to control the centrosome. The centrosome is a cellular machine responsible for coordinating how cells accurately sort their chromosomes when they divide, and defects in its regulation underlie a number of diseases.